UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Strategy Inc
MSTR
|
+$1.21B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$855M |
| 3 |
Microsoft
MSFT
|
+$810M |
| 4 |
Advanced Micro Devices
AMD
|
+$805M |
| 5 |
Boeing
BA
|
+$739M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$561M |
| 2 |
Amneal Pharmaceuticals
AMRX
|
+$169M |
| 3 |
Eli Lilly
LLY
|
+$161M |
| 4 |
Unity
U
|
+$158M |
| 5 |
State Street SPDR S&P Regional Banking ETF
KRE
|
+$127M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.49% |
| 2 | Financials | 9.06% |
| 3 | Consumer Discretionary | 7.01% |
| 4 | Healthcare | 6.25% |
| 5 | Industrials | 6.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SA
5101
Seabridge Gold
SA
$3.35B
| $1.3M | ﹤0.01% |
114,128
+85,109
| +293% | +$1.31M |
|
|
MTLS
5102
Materialise
MTLS
$396M
| $1.3M | ﹤0.01% |
184,637
+97,300
| +111% | +$643K |
|
5103
Skillsoft
SKIL
$81.6M
| $1.29M | ﹤0.01% |
53,860
+47,222
| +711% | +$771K |
|
5104
Invesco KBW High Dividend Yield Financial ETF
KBWD
$427M
| $1.29M | ﹤0.01% |
87,745
+51,396
| +141% | +$774K |
|
5105
CALL
Lazard
LAZ
$4.31B
| $1.29M | ﹤0.01% |
+25,000
| New | +$1.34M |
|
5106
Orion
OEC
$409M
| $1.29M | ﹤0.01% |
81,481
+14,410
| +21% | +$243K |
|
|
RPC
5107
Ridgepost Capital
RPC
$991M
| $1.29M | ﹤0.01% |
101,958
-24,823
| -20% | -$303K |
|
5108
Adams Diversified Equity Fund
ADX
$3.2B
| $1.28M | ﹤0.01% |
63,511
+7,948
| +14% | +$170K |
|
5109
FlexShares Quality Dividend Defensive Index Fund
QDEF
$562M
| $1.28M | ﹤0.01% |
18,261
+4,127
| +29% | +$297K |
|
5110
Tango Therapeutics
TNGX
$4.41B
| $1.28M | ﹤0.01% |
414,473
-26,358
| -6% | -$122K |
|
|
ABVX
5111
Abivax
ABVX
$11.4B
| $1.28M | ﹤0.01% |
174,873
+174,182
| +25,207% | +$1.6M |
|
5112
Legacy Housing
LEGH
$694M
| $1.28M | ﹤0.01% |
51,819
+45,567
| +729% | +$1.18M |
|
5113
State Street SPDR US Small Cap Low Volatility Index ETF
SMLV
$261M
| $1.28M | ﹤0.01% |
10,019
+1,043
| +12% | +$137K |
|
5114
Nuveen Core Equity Alpha Fund
JCE
$288M
| $1.28M | ﹤0.01% |
80,304
+19,147
| +31% | +$296K |
|
5115
PUT
Royalty Pharma
RPRX
$25.3B
| $1.28M | ﹤0.01% |
+50,000
| New | +$1.33M |
|
5116
Capital Group Dividend Growers ETF
CGDG
$5.62B
| $1.27M | ﹤0.01% |
43,009
+37,001
| +616% | +$1.12M |
|
5117
Algoma Steel
ASTL
$431M
| $1.27M | ﹤0.01% |
130,211
+118,587
| +1,020% | +$1.22M |
|
5118
ProShares UltraShort QQQ
QID
$247M
| $1.27M | ﹤0.01% |
38,841
-84,100
| -68% | -$2.85M |
|
5119
Inseego
INSG
$90.5M
| $1.27M | ﹤0.01% |
123,479
+121,086
| +5,060% | +$1.78M |
|
5120
Fresenius Medical Care
FMS
$12.9B
| $1.26M | ﹤0.01% |
55,795
+12,640
| +29% | +$274K |
|
5121
Invesco Bond Fund
VBF
$169M
| $1.26M | ﹤0.01% |
81,779
-33,262
| -29% | -$536K |
|
|
PRSU
5122
Pursuit Attractions and Hospitality Inc
PRSU
$1.25B
| $1.26M | ﹤0.01% |
29,673
+9,773
| +49% | +$403K |
|
|
CDTX
5123
DELISTED
Cidara Therapeutics
CDTX
| $1.26M | ﹤0.01% |
46,871
+40,994
| +698% | +$666K |
|
|
CGC
5124
Canopy Growth
CGC
$410M
| $1.26M | ﹤0.01% |
459,804
+455,239
| +9,972% | +$1.81M |
|
5125
CALL
SiriusXM
SIRI
$10.1B
| $1.25M | ﹤0.01% |
+55,000
| New | +$1.4M |
|
Similar funds
UBS Group's Q4 2024 Portfolio in Review
As of Q4 2024, UBS Group held 10,816 positions worth $541B, up 18% from $459B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
UBS Group deployed $80.6B of net new capital in Q4 2024, opening 1,382 new positions and adding to 6,044 existing holdings. Its largest new stake was Primo Brands: 1,234,826 shares worth $38M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was UnitedHealth, an estimated $561M trimmed.
- UBS Group's largest Q4 2024 buy was Primo Brands: 1,234,826 shares worth $38M.
- UBS Group added most to Strategy Inc in Q4 2024, an estimated $1.21B increase.
- UBS Group's biggest Q4 2024 reduction was UnitedHealth, cutting an estimated $561M.
- UBS Group fully exited CATALENT, INC. in Q4 2024, selling an estimated $86M.
- UBS Group's ten largest holdings make up 16% of its $541B portfolio in Q4 2024.
- UBS Group opened 1,382 new positions and closed 943 in Q4 2024.
- UBS Group's portfolio value rose 18% quarter-over-quarter to $541B.
Based on UBS Group's 13F filing for Q4 2024, filed 14 Feb 2025.